Germany-based Vivian Lab raises €300,000 to address menopause care gap
The €300,000 funding will be used to enhance the platform, improve user experience, and expand into new markets, particularly the DACH region.
Vivian Lab, a Munich-based digital health startup, has announced the successful completion of its first funding round, raising €300,000 from Eleven Ventures, an early-stage venture capital firm active in Central and Eastern Europe. The investment comes just six months after the company’s launch.
Founded by an all-female team with backgrounds in technology, healthcare, and HR transformation, Vivian Lab aims to fill significant gaps in traditional healthcare systems by providing accessible, comprehensive, and personalized care for women. The founders, based in Munich (Germany), Athens (Greece), and London (UK), have leveraged their diverse expertise to develop digital programs that support women through critical life stages, including menopause.
“The name comes from the Latin word for ‘alive,’ as the goal to empower women to feel full of life in every stage of their journey,” said Gina Tiriakidou, Co-founder and CEO of Vivian Lab. “We are deeply grateful for the support from Eleven Ventures, who share our commitment to bringing fundamental changes to women’s healthcare. This funding is a crucial step in our journey to expand our offerings and reach more women who need support. More importantly, Eleven is a strategic partner on this journey, with a highly successful track record in healthcare investments, so we can greatly benefit from their guidance and experience. We couldn’t be more proud and grateful to belong to the Eleven community.”
Vivian Lab’s flagship program focuses on menopause, a life stage affecting all women but often underserved due to stigma and lack of education. The platform offers tailored support and resources, integrating educational content, telehealth consultations, personalized treatment plans, community support, and AI assistants. By doing so, it empowers women to better manage and improve their symptoms naturally.
“Menopause has over 30 different symptoms, but due to stigma and a lack of education, many women fail to recognize them,” Tiriakidou stated. “Additionally, doctors often misdiagnose these symptoms due to insufficient focus on menopause, leading to increased costs for insurance companies and preventing women from receiving comprehensive support.”
The economic impact is substantial. Women are often forced to leave the workforce earlier due to unmanaged menopause symptoms, causing a €150 billion gap for employers and insurance companies. Vivian Lab aims to reduce this gap by offering preventative care solutions that increase productivity, retain talent, and decrease costs.
The startup has already attracted significant enterprise interest, serving large clients including pharmaceutical companies, banks, hospitals, and multinationals like Bayer.
The €300,000 funding will be used to enhance the platform, improve user experience, and expand into new markets, particularly the DACH region. Vivian Lab also plans to broaden its programs to include fertility, pregnancy, and postpartum care, aiming to provide comprehensive support throughout a woman’s life.
